http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 13 Aug 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html <p>ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management will participate in the Evercore ISI 2nd Annual China Biotech Summit, being held August 17-19, 2026 at The Ritz-Carlton Shanghai, Pudong.</p> <p>Management will participate in a fireside chat moderated by the Evercore research team and one-on-one investor meetings during the conference.</p> http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Participate+in+the+Evercore+2nd+Annual+China+Biotech+Summit/26916729.html Thu, 13 Aug 2026 08:00:00 -0400 36X 6855 A.50214655 AAPG O.10869727 O.38659577 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Press+Releases/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html <p align="center"><em>In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),<br/></em><em>please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.<br/><br/>The corrected release follows:</em></p> <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, http://www.streetinsider.com/Globe+Newswire/CORRECTION%3A+Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26871324.html Wed, 05 Aug 2026 09:07:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that it will release its six months 2026 unaudited interim results and provide business updates at 9:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 9:00 pm Hong Kong Time (HKT) on August 19, 2026.</p> <p align="justify">Analysts and investors are invited to join the investor webcast with Q&amp;A, http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html Wed, 05 Aug 2026 08:00:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that it will release its six months 2026 unaudited interim results and provide business updates at 9:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 9:00 pm Hong Kong Time (HKT) on August 19, 2026.</p> <p align="justify">Analysts and investors are invited to join the investor webcast with Q&amp;A, http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html Wed, 05 Aug 2026 08:00:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that it will release its six months 2026 unaudited interim results and provide business updates at 9:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 9:00 pm Hong Kong Time (HKT) on August 19, 2026.</p> <p align="justify">Analysts and investors are invited to join the investor webcast with Q&amp;A, http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html Wed, 05 Aug 2026 08:00:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that it will release its six months 2026 unaudited interim results and provide business updates at 9:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 9:00 pm Hong Kong Time (HKT) on August 19, 2026.</p> <p align="justify">Analysts and investors are invited to join the investor webcast with Q&amp;A, http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html Wed, 05 Aug 2026 08:00:00 -0400 36X 6855 AAPG O.38659577 http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html <p align="justify">ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that it will release its six months 2026 unaudited interim results and provide business updates at 9:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 9:00 pm Hong Kong Time (HKT) on August 19, 2026.</p> <p align="justify">Analysts and investors are invited to join the investor webcast with Q&amp;A, http://www.streetinsider.com/Globe+Newswire/Ascentage+Pharma+to+Report+2026+Six+Month+Interim+Results+and+Provide+Corporate+Update+on+August+19%2C+2026/26870543.html Wed, 05 Aug 2026 08:00:00 -0400 36X 6855 AAPG O.38659577